Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Chelsea Bernheisel"'
Autor:
Shivi Jain, Terry Gernsheimer, Scott Kolodny, Chelsea Bernheisel, Michael Vredenburg, Sandhya R. Panch
Publikováno v:
Platelets, Vol 34, Iss 1 (2023)
Avatrombopag is an oral thrombopoietin receptor agonist (TPO-RA) that was approved in the US in 2019 for treatment of chronic immune thrombocytopenia (ITP). This post hoc analysis of the pivotal phase III study (NCT01438840) of avatrombopag in adult
Externí odkaz:
https://doaj.org/article/713515575b754828a04a228462e6b23f
Autor:
Hanny Al-Samkari, Debbie Jiang, Terry Gernsheimer, Howard Liebman, Susie Lee, Chelsea Bernheisel, Matthew Wojdyla, Michael Vredenburg, Adam Cuker
Publikováno v:
Research and Practice in Thrombosis and Haemostasis. 7:100134
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42b544c8acee0649805eda9af1367bee
https://doi.org/10.1016/j.rpth.2023.100134
https://doi.org/10.1016/j.rpth.2023.100134
Autor:
Debbie Jiang, Adam Cuker, Howard A. Liebman, Hanny Al-Samkari, Matthew Wojdyla, Chelsea Bernheisel, Terry B. Gernsheimer, Scott Kolodny, Michael Vredenburg, Brian Jamieson, Susie Lee
Publikováno v:
Blood. 138:1015-1015
BACKGROUND : Thrombopoietin receptor agonists (TPO-RAs) are widely utilized second-line treatments for immune thrombocytopenia (ITP). The TPO-RAs eltrombopag and romiplostim have been FDA approved for over a decade with established efficacy and safet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4dd0ade4eeaf09214d1d2741e7bb449
https://doi.org/10.1182/blood-2021-151321
https://doi.org/10.1182/blood-2021-151321